Patents by Inventor Barbara Conradt

Barbara Conradt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

EGL-1, a new protein required for programmed cell death in C. elegans that interacts with the BCL-2-like protein CED-9

Patent number: 6596495

Abstract: The invention provides a novel protein, EGL-1, involved in cell death and methods for identifying compounds and genes which affect the cell death pathway.

Type: Grant

Filed: May 28, 1998

Date of Patent: July 22, 2003

Assignee: Massachusetts Institute of Technology

Inventors: H. Robert Horvitz, Barbara Conradt

EGL-1, a new protein required for programmed cell death in C. elegans that interacts with the BCL-2-like protein CED-9